149 related articles for article (PubMed ID: 10568876)
1. Serum IFN-gamma and IL-10 levels before and after specific immunotherapy in patients with allergic rhinitis.
Keskin G; Inal A; Ali Sari R; Sengül A; Sahin M; Turgay M; Kinikli G
Allergol Immunopathol (Madr); 1999; 27(5):261-4. PubMed ID: 10568876
[TBL] [Abstract][Full Text] [Related]
2. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
4. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
5. Allergen immunotherapy in intermittent allergic rhinitis reduces the intracellular expression of IL-4 by CD8+ T cells.
Glück J; Rogala B; Rogala E; Oleś E
Vaccine; 2007 Dec; 26(1):77-81. PubMed ID: 18054415
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy.
Lou W; Wang C; Wang Y; Han D; Zhang L
Int Arch Allergy Immunol; 2012; 159(4):391-8. PubMed ID: 22846686
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
8. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
9. [The effect of specific immunotherapy on the regulation of Th1/Th2 cell ratio of the patients with allergic rhinitis in serum].
Xiao C; Li H; Li H; Cheng Z; Qin J; Zhou W; He Q; Xu X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Oct; 24(20):924-7. PubMed ID: 21171297
[TBL] [Abstract][Full Text] [Related]
10. Trichuris suis ova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine response.
Bourke CD; Mutapi F; Nausch N; Photiou DM; Poulsen LK; Kristensen B; Arnved J; Rønborg S; Roepstorff A; Thamsborg S; Kapel C; Melbye M; Bager P
Clin Exp Allergy; 2012 Nov; 42(11):1582-95. PubMed ID: 23106658
[TBL] [Abstract][Full Text] [Related]
11. [The serum level transformation of IFN-gamma, IL-4 and IgE before and after SIT in patients with allergic rhinitis].
Li Y; Li P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Apr; 27(8):397-9, 403. PubMed ID: 23858719
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy.
Ohashi Y; Nakai Y; Sakamoto H; Ohno Y; Sugiura Y; Okamoto H; Tanaka A; Kakinoki Y; Kishimoto K; Hayashi M
Ann Allergy Asthma Immunol; 1996 Sep; 77(3):203-8. PubMed ID: 8814045
[TBL] [Abstract][Full Text] [Related]
13. Effect of allergen immunotherapy on soluble adhesion molecules.
Pereira-Santos MC; Pregal AL; Spínola-Santos A; Alonso E; Palma-Carlos ML; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Jun; 33(6):225-8. PubMed ID: 11505805
[TBL] [Abstract][Full Text] [Related]
14. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
15. The early effect of specific immunotherapy on lymphocyte response to PHA and allergens in atopic patients with allergic rhinitis.
Kinikli G; Tülek N; Sentürk T; Turgay M; Tutkak H; Duman M; Tokgöz G
Allergol Immunopathol (Madr); 1996; 24(2):65-9. PubMed ID: 8933891
[TBL] [Abstract][Full Text] [Related]
16. Long-term allergen-specific immunotherapy correlates with long-term allergen-specific immunological tolerance.
Ali I; Goksal K; Ozan B; Gulsen D
Adv Ther; 2008 Jan; 25(1):29-36. PubMed ID: 18224290
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
18. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2006 Nov; 24(47-48):6990-3. PubMed ID: 17011086
[TBL] [Abstract][Full Text] [Related]
19. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
[TBL] [Abstract][Full Text] [Related]
20. Carry-over effect on IFN-gamma production induced by allergen-specific immunotherapy.
Ciprandi G; Sormani MP; Filaci G; Fenoglio D
Int Immunopharmacol; 2008 Dec; 8(12):1622-5. PubMed ID: 18691675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
